Q32 Bio Inc.
QTTB$10M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWALTHAM
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
This month
Market Overview
Stock performance and key metrics
QTTB News
Catalyst Timeline
1 upcoming, 0 past
Phase 2Next
bempikibart (ADX-914) Phase 2 Est. Readout
June 2026~Estimatedbempikibart (ADX-914)75
Primary completion for bempikibart (ADX-914) trial (NCT06018428) in Alopecia Areata
SourceDrug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
bempikibart (ADX-914) | Phase 2 | Alopecia Areata | - | - |
ADX-914 | Phase 2 | Atopic Dermatitis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply